Use of Deferoxamine in the Treatment of Aluminum Overload in Dialysis Patients
- 1 January 1988
- journal article
- Published by Wiley in Seminars in Dialysis
- Vol. 1 (1) , 55-61
- https://doi.org/10.1111/j.1525-139x.1988.tb00769.x
Abstract
No abstract availableThis publication has 70 references indexed in Scilit:
- Aluminum-Related Bone Disease in Mild and Advanced Renal Failure: Evidence for High Prevalence and Morbidity and Studies on Etiology and DiagnosisAmerican Journal of Nephrology, 1986
- Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysisThe Journal of Pediatrics, 1985
- Effect of Parathyroidectomy on Bone Aluminum Accumulation in Chronic Renal FailureNew England Journal of Medicine, 1985
- The Use of Deferoxamine in the Management of Aluminum Accumulation in Bone in Patients with Renal FailureNew England Journal of Medicine, 1984
- Aluminum Intoxication from Aluminum-Containing Phosphate Binders in Children with Azotemia Not Undergoing DialysisNew England Journal of Medicine, 1984
- Plasma aluminum is bound to transferrinLife Sciences, 1983
- The Prevalence of Bone Aluminum Deposition in Renal Osteodystrophy and Its Relation to the Response to Calcitriol TherapyNew England Journal of Medicine, 1982
- Chelating Agents in MedicineJournal of Toxicology: Clinical Toxicology, 1982
- Aluminum removal by hemodialysisKidney International, 1981
- Gastrointestinal Absorption of Aluminum from Aluminum-Containing AntacidsNew England Journal of Medicine, 1977